European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Results from ATOLL, a phase 3 randomised trial comparing two anticoagulants in primary PCI for ST elevation MI, show that the low molecular weight heparin enoxaparin may provide better outcomes in such cases than the traditionally used unfractionated heparin.

• Download the presentation slides and read the Congress Reports by presenter Gilles Montalescot and discussant Harvey White

Hot Line II Results: LESSON I trial provides preliminary evidence for the therapeutic benefit of the newer generation everolimus-eluting stent over the previous gold standard, the early generation sirolimus-eluting stent.

Moreover, LESSON I provides evidence that the formation of blood clots (stent thrombosis) – the principal shortcoming of early generation drug-eluting stents – may be diminished with the newer generation everolimus-eluting stent....

Hot Line II results: With both bleeding und thrombotic complications having a negative effect on PCI outcomes, increasing efforts have been made to improve PCI anticoagulation regimens.

• Read the congress reports and view the presentations slides by presenter Stefanie Schultz and discussant Christian Hamm

This guideline, jointly developed by the ESC and the European Association for Cardio-Thoracic Surgery (EACTS), is a reflection of the importance of a team approach in patient selection and management. It provide recommendations for the diagnosis and performance of revascularisation according to anatomy and clinical presentation.

The document also gives guidance on medical therapy, especially the anti-thrombotic  therapy which accompanies revascularisation, as well as recommendations about the organisation of PCI centres and patient information.